Cabaletta Bio Inc. Insider Trading
CABA
Insiders bought 296K on the open market and sold nothing.
Get an email when CABA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jan 21 | David J. Chang Chief Medical Officer | Bought | 8,800 | $2.26 | 20K | New | Form 4 |
| Jan 21 | Gwendolyn Binder President, Science & Tech. | Bought | 11,312 | $2.19 | 25K | 57% | Form 4 |
| Jan 21 | Shawn Tomasello Director | Bought | 22,725 | $2.21 | 50K | New | Form 4 |
| Jan 21 | Steve Gavel Chief Commercial Officer | Bought | 22,170 | $2.27 | 50K | New | Form 4 |
| Jan 21 | Catherine Bollard Director | Bought | 4,405 | $2.27 | 10K | 441% | Form 4 |
| Jan 21 | Steven Nichtberger President & CEO | Bought | 45,000 | $2.24 | 101K | 3.3% | Form 4 |
| Jan 21 | Mark Simon Director | Bought | 11,061 | $2.28 | 25K | 7.7% | Form 4 |
| Jan 21 | Michael Gerard General Counsel | Bought | 6,600 | $2.27 | 15K | New | Form 4 |
- Jan 21David J. ChangChief Medical Officer · bought 8,800 at $2.2620KNew position
- Jan 21Gwendolyn BinderPresident, Science & Tech. · bought 11,312 at $2.1925K57% of stake
- Jan 21Shawn TomaselloDirector · bought 22,725 at $2.2150KNew position
- Jan 21Steve GavelChief Commercial Officer · bought 22,170 at $2.2750KNew position
- Jan 21Catherine BollardDirector · bought 4,405 at $2.2710K441% of stake
- Jan 21Steven NichtbergerPresident & CEO · bought 45,000 at $2.24101K3.3% of stake
- Jan 21Mark SimonDirector · bought 11,061 at $2.2825K7.7% of stake
- Jan 21Michael GerardGeneral Counsel · bought 6,600 at $2.2715KNew position
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CABA
Held by ETFs
CABA is in 13 US ETFs. The largest of them, with CABA's weight in each:
Spot a number that looks wrong? Check it in CABA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CABA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.